Interpreting the current data on transcatheter aortic valve implantation: A difficult task

European Heart Journal, Supplement

Volumn 12, Issue SUPPL. E, 2010, Pages

  Piazza, Nicolo ^a,b   Van Mieghem, Nicolas ^a   Tzikas, Apostolos ^a   Lange, Rüdiger ^b   De Jaegere, Peter ^a   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA VALVE REPLACEMENT; AORTIC VALVE REPAIR; CLINICAL TRIAL; ENDOCARDITIS; HUMAN; MEDICAL RESEARCH; MORTALITY; OPEN HEART SURGERY; PRIORITY JOURNAL; PROSTHETIC VALVE DYSFUNCTION; PROSTHETIC VALVE THROMBOSIS; REVIEW; SAFETY; SURGICAL RISK; SURVIVAL; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME;

EID: 77957728073     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/suq011     Document Type: Review

References (19)

1. Piazza N, Cutlip DE, Onuma Y, Kappetein AP, de Jaegere P, Serruys PW. Clinical endpoints in transcatheter aortic valve implantation: a call to ARC for standardised definitions. EuroIntervention 2009;5:29-31.
2. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008;4:242-249.
3. Piazza N, van Gameren M, Jüni P, Wenaweser P, Carrel T, Onuma Y, Gahl B, Hellige G, Otten A, Kappetein A, Takkenberg J, van Domburg R, de Jaegere P, Serruys P, Windecker S. A comparison of patient characteristics and 30-day mortality outcomes after transcatheter aortic valve implantation and surgical aortic valve replacement for the treatment of aortic stenosis: a two-center study. EuroIntervention 2009;5:580-588.
4. Walther T, Schuler G, Borger MA, Kempfert J, Seeburger J, Ruckert Y, Ender J, Linke A, Scholz M, Volkmar F, Mohr F. Transapical aortic valve implantation in 100 consecutive patients: comparison to propensitymatched conventional aortic valve replacement. Eur Heart J 2010;31:1398-1403.
5. Thomas M, Wendler O. Transcatheter aortic valve implantation (TAVI): how to interpret the data and what data is required? EuroIntervention 2009;5:25-27.
6. Piazza N, Cutlip D, Onuma Y, Kappetein AP, de Jaegere P, Serruys PW. Clinical endpoints in transcatheter aortic valve implantation: a call to ARC for standardized definitions. EuroIntervention 2009;5:29-31.
7. Piazza N, Onuma Y, de Jaegere P, Serruys PW. Guidelines for reporting mortality and morbidity after cardiac valve interventions-need for a reappraisal? Ann Thoracic Surg 2009;87:357-358. discussion 359-360.
8. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D, Tapiero S, Litzler PY, Bessou JP, Babaliaros V. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 2006;47:1214-1223.
9. Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R, Sinhal A, Carere RG, Munt B, Ricci D, Ye J, Cheung A, Lichtenstein SV. Percutaneous transarterial aortic valve replacement in selected highrisk patients with aortic stenosis. Circulation 2007;116:755-763.
10. Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L, Mueller R, Menichelli M, Schmidt T, Zickmann B, Iversen S, Stone GW. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 2006;114:1616-1624.
11. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second-and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69-76.
12. Schofer J, Schluter M, Treede H, Franzen OW, Tubler T, Pascotto A, Low RI, Bolling SF, Meinertz T, Reichenspurner H. Retrograde transarterial implantation of a nonmetallic aortic valve prosthesis in high-surgical-risk patients with severe aortic stenosis. A first-in-man feasibility and safety study. Circ Cardiovasc Intervent 2008;1:126-133.
13. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18F) CoreValve ReValving system-results from the multicenter, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008;4:242-249.
14. Grube E, Buellesfeld L, Mueller R, Sauren B, Zickmann B, Nair D, Beucher H, Felderhoff T, Iversen S, Gerckens U. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system. Circ Cardiovasc Intervent 2008;1:167-175.
15. Ussia G, Mulè M, Barbanti M, Cammalleri V, Scarabelli M, Immè S, Capodanno D, Tamburino C. Quality of life assessment in elderly patients after percutaneous aortic valve replacement. Eur Heart J 2009;30:1790-1796.
16. Bleiziffer S, Ruge H, Mazzitelli D, Schreiber C, Hutter A, Laborde JC, Bauernschmitt R, Lange R. Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team. Eur J Cardiothorac Surg 2009;35:615-620. Discussion 620-611.
17. Webb JG, Altwegg L, Boone RH, Cheung A, Ye J, Lichtenstein S, Lee M, Masson JB, Thompson C, Moss R, Carere R, Munt B, Nietlispach F, Humphries K. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation 2009;119:3009-3016.
18. Akins CW, Miller DC, Turina MI, Kouchoukos NT, Blackstone EH, Grunkemeier GL, Takkenberg JJ, David TE, Butchart EG, Adams DH, Shahian DM, Hagl S, Mayer JE, Lytle BW. Guidelines for reporting mortality and morbidity after cardiac valve interventions. Ann Thorac Surg 2008;85:1490-1495. (Pubitemid 351381711)
19. Piazza N, Onuma Y, de Jaegere P, Serruys PW. Guidelines for reporting mortality and morbidity after cardiac valve interventions - need for reappraisal?. Ann Thorac Surg 2009;87:357-8; Discussion 359-60.